Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2002
05/02/2002EP1200605A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
05/02/2002EP1200604A1 Production of proteins
05/02/2002EP1200603A1 Production of proteins by autoproteolytic cleavage
05/02/2002EP1200602A1 Dsp-11 dual-specificity map kinase phophatase
05/02/2002EP1200601A1 Method for the production of l-amino acids from their racemic n-acetyl-d, l-derivatives by enzymatic racemate cleavage by means of isolated recombinant enzymes
05/02/2002EP1200600A2 Monocellular or multicellular organisms for the production of riboflavin
05/02/2002EP1200599A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB)
05/02/2002EP1200598A2 Method for production of transgenic plants with increased tocopherol content
05/02/2002EP1200597A1 Method for preparing 1,3-propanediol by a recombinant micro-organism in the absence of coenzyme b12 or one of its precursors
05/02/2002EP1200596A2 Human synthetases
05/02/2002EP1200576A2 Dna's encoding proteins with signal peptides
05/02/2002EP1200574A1 Cellobiohydrolase reduced glycosylation variants: cbhin45a; cbhin270a; and cbhin384a
05/02/2002EP1200572A1 Antisense modulation of liver glycogen phosphorylase expression
05/02/2002EP1200568A2 Purine metabolism genes in plants
05/02/2002EP1200567A1 Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases
05/02/2002EP1200566A2 Glucoamylase variant
05/02/2002EP1200565A2 Crystallization and structure determination of staphylococcus aureus thymidylate kinase
05/02/2002EP1200564A2 USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN
05/02/2002EP1200561A1 Recombinant stabile cell clone, its production and use thereof
05/02/2002EP1200553A1 Metabolic engineering of amino acid production
05/02/2002EP1200478A1 Method for assaying compounds affecting smooth muscle contractile state
05/02/2002EP1200117A2 Lipoprotein lipase (lpl) variant therapeutics
05/02/2002EP1200116A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
05/02/2002EP1146875A4 Myt1 kinase inhibitors
05/02/2002EP0876205B1 Particles having a polymeric shell and their production
05/02/2002EP0573500B2 Fused genes and their use for determining the presence of metals or of xenobiotic compounds
05/02/2002EP0455665B1 Hybrid seed production
05/02/2002DE10145585A1 Für die Gene hemD und hemB kodierende Nukleotidsequenzen Encoding genes hemD and hemB nucleotide sequences
05/02/2002DE10051175A1 Cytochrom P450 Monoxygenasen aus thermophilen Bakterien Cytochrome P450 monooxygenases from thermophilic bacteria
05/02/2002CA2427473A1 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
05/02/2002CA2427024A1 Methods for screening compounds that modulate lipid metabolism
05/02/2002CA2426465A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/02/2002CA2426463A1 Novel aggrecanase molecules
05/02/2002CA2425897A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/02/2002CA2421679A1 Monocotyledon plant cells and plants which synthesise modified starch
05/01/2002CN1347455A Novel meannose isomerase and DNA encoding enzyme
05/01/2002CN1347454A Method for improving agronomic and nutritional value of plants
05/01/2002CN1347452A Alpha-agarase and process for producing same
05/01/2002CN1347451A Polypeptides having branching enzyme activity and nucleic acids encoding same
05/01/2002CN1347449A 芽孢杆菌蛋白生产细胞 Bacillus cell protein production
05/01/2002CN1347283A eNOS mutations useful for gene therapy and therapeutic screening
05/01/2002CN1346889A Method for generating active isdime AMV-RT in procaryotic cell
05/01/2002CN1346888A Method for producing transgene non-human mammal
05/01/2002CA2327172A1 Recombinant zymomonas mobilis with improved xylose utilization
04/2002
04/30/2002US6380465 Cytochrome P450 enzymes and related compounds and methods
04/30/2002US6380464 Plant flavonol synthase homologs
04/30/2002US6380463 Gene expression cassette
04/30/2002US6380462 Method for increasing stearate content in soybean oil
04/30/2002US6380461 Production of pathogen resistant plants
04/30/2002US6380460 Insertion tolerance gene into plant; genetic engineering
04/30/2002US6380459 Compositions and methods for the modification of gene expression
04/30/2002US6380372 Barley gene for Thioredoxin and NADP-thioredoxin reductase
04/30/2002US6380171 Administering antisense nucleic acid having a nucleotide sequence to suppress expression of pro-protein converting enzyme 5 (pc5) gene or to inhibit pc5 activity for reducing restenosis occuring at injured vascular site
04/30/2002US6380140 Enzyme granules containing phosphated starch
04/30/2002US6379968 A method for creating transgenic plants expressing exogenous glucose pyrophosphorylase in the starch producing plastids
04/30/2002US6379950 Recombinant, active caspases and uses thereof
04/30/2002US6379947 At least one hydroxyl groups has been sulfated; endo-fucoidan lyase; bacterium of the genus gucoidanobacter that has menaquinone in the electron transport chain; sugars useful for analyzing the fucoidan structure
04/30/2002US6379942 Chemically modified enzymes with multiple charged variants
04/30/2002US6379941 Human kinesin-related protein HsKrp5
04/30/2002US6379940 Stable composition comprising a nuclease and a phosphatase
04/30/2002US6379938 Epoxide hydrolase
04/30/2002US6379934 Process for the fermentative preparation of L-amino acids using coryneform bacteria
04/30/2002US6379933 Method of transferring at least two saccharide units with a polyglycosyltransferase
04/30/2002US6379931 Derived from spacer reagent 3-(4,4'-dimethoxytrityloxy)propane-1-((2-cyanoethyl)-(n,n-diisopropyl)) -phosphoramidite; use treating viral and rna-mediated diseases such as hiv
04/30/2002US6379928 Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
04/30/2002US6379924 Amplifying protein products by using fungal cells having a plasmid with a funcional coding sequence and also having a modified level of ubiquitin conjugating enzymes activity; then culturing the cell to produce a fungal derived product
04/30/2002US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease
04/30/2002US6379912 Motor proteins and method for their use
04/30/2002US6379722 Human S-adenosyl-L-methionine methyltransferase
04/30/2002US6379721 Process for preparation of α-amylase from Tinospora cordifolia Miers useful for starch saccharification
04/30/2002US6379665 Therapy for rheumatic diseases; antiarthritic agents
04/30/2002US6379664 Administering human lense thiotransferase inhibitor polypeptide
04/30/2002US6379599 Crosslinking, crushing, solvent extraction
04/30/2002US6379553 Solubilizing; heparin sepharose chromatography; detection
04/30/2002CA2151045C Platelet-activating factor acetylhydrolase
04/30/2002CA2147162C Remyelination using neural stem cells
04/30/2002CA2114163C Method for stabilizing antigenicity of myeloperoxidase
04/30/2002CA2107804C Newly characterised oxalate oxidase and uses therefor
04/30/2002CA2053547C Biocatalytic oxidation using soybean and other legume peroxidases
04/30/2002CA2020247C Antibodies reactive with human carcinomas
04/27/2002CA2360015A1 Angiotensin i-converting enzyme inhibitory substance
04/25/2002WO2002033114A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033113A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033112A2 Protein-protein interactions in neurodegenerative diseases
04/25/2002WO2002033109A2 Fermentation method for production of heterologous gene products in lactic acid bacteria
04/25/2002WO2002033105A2 Reducing oxidative stress of plants by increasing glutathione content
04/25/2002WO2002033100A2 Regulation of human adenylate cyclase, type iv
04/25/2002WO2002033099A2 Human kinases
04/25/2002WO2002033098A1 Process for producing viral rna polymerase
04/25/2002WO2002033097A2 Regulation of human sulfotransferase
04/25/2002WO2002033096A2 Regulation of human serine-threonine protein kinase
04/25/2002WO2002033095A2 Regulation of human serine-threonine protein kinase
04/25/2002WO2002033093A2 Aggrecanase molecules
04/25/2002WO2002033088A2 Human carboxypeptidase, scramblase, and protocadherin family members and uses thereof
04/25/2002WO2002033084A2 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
04/25/2002WO2002033075A1 Novel polypeptide--- a human sialyl:transferase (hst30-1)11.99 and polynucleotide encoding it
04/25/2002WO2002033070A1 N-acetylneuraminic acid synthase and dna encoding this enzyme
04/25/2002WO2002033064A1 Zipper protein kinase and uses thereof
04/25/2002WO2002033063A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
04/25/2002WO2002033062A1 REGULATION OF HUMAN ACYL-CoA DEHYDROGENASE